Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment.

Nature reviews. Clinical oncology ·Vol. 11 ·No. 11 ·2014-11-00 ·Pages 630-2

Rosenberg SA

Abstract

暂无摘要

MeSH Terms

Humans Immunity, Active Immunotherapy/methods,trends Leukemia/immunology,therapy Neoplasms/immunology,therapy

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Rosenberg Steven A

National Cancer Institute, 10 Center Drive MSC 1201, Bethesda, MD 20892, USA.

References (10)

10 references, click to expand

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
N Engl J Med. 2012 Jun 28;366(26):2455-65 PMID: 22658128
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
Nat Med. 2008 Nov;14(11):1264-70 PMID: 18978797
Improved survival with ipilimumab in patients with metastatic melanoma.
N Engl J Med. 2010 Aug 19;363(8):711-23 PMID: 20525992
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
N Engl J Med. 2012 Jun 28;366(26):2443-54 PMID: 22658127
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.
Science. 2014 May 9;344(6184):641-5 PMID: 24812403
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
J Clin Oncol. 2014 Mar 10;32(8):798-808 PMID: 24344220
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.
Clin Cancer Res. 2011 Jul 1;17(13):4550-7 PMID: 21498393
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Blood. 2010 Nov 18;116(20):4099-102 PMID: 20668228
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
N Engl J Med. 2010 Jul 29;363(5):411-22 PMID: 20818862
Cancer regression in patients after transfer of genetically engineered lymphocytes.
Science. 2006 Oct 6;314(5796):126-9 PMID: 16946036

Article Info

Journal

Nature reviews. Clinical oncology

Abbr.

Nat Rev Clin Oncol

ISSN

1759-4782

DOI

10.1038/nrclinonc.2014.174

Published

2014-11-00

Epub

2014-00-14

Pages

630-2

Language

English

Region

England

NLM ID

101500077

PMCID

PMC6310157

Subset

Grants

Intramural NIH HHS · Z01 BC010984-01 · United States

External Links

PubMed source DOI: 10.1038/nrclinonc.2014.174 PMC Full Text View journal details

Analysis Services

Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment.

Contact

WeChat Official Account